Screener
Candel Therapeutics, Inc. CADL Net margin
Discontinued — last reported Q4 '22
Net margin at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024. Open the filing →
- Filed
- Mar 28, 2024
- Fiscal year
- FY2023
- Accession
- 0000950170-24-037637
FAQ
- What is Candel Therapeutics, Inc.'s net margin?
- Candel Therapeutics, Inc. (CADL) reported net margin of -15,156.5% in Q4 2022.
- How has Candel Therapeutics, Inc.'s net margin changed year-over-year?
- Candel Therapeutics, Inc.'s net margin increased by 50.2% year-over-year, from -30,419.4% to -15,156.5%.
- What is the long-term trend for Candel Therapeutics, Inc.'s net margin?
- Over 2 years (2020 to 2022), Candel Therapeutics, Inc.'s net margin has grown at a 3.5% compound annual growth rate (CAGR), from -14,144% to -15,156.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Candel Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude